Q2 2020 Emergent BioSolutions Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Emergent BioSolutions Q2 Earnings Conference Call. (Operator Instructions)
I would now like to hand the conference to Emergent BioSolutions. Please go ahead.
Thank you, Joelle, and good afternoon, everyone. My name is Bob Burrows, Vice President of Investor Relations for Emergent. Thank you for joining us today as we discuss the operational and financial results for the second quarter and 6 months ended June 30, 2020. As is customary, today's call is open to all participants and, in addition, the call is being recorded and is copyrighted by Emergent BioSolutions.
The agenda for today's call will follow a traditional path with prepared comments from Bob Kramer, President and Chief Executive Officer; and Rich Lindahl, Chief Financial Officer. Other members of the senior team are present and available during the Q&A session following our prepared comments.
Before beginning, during today's call, either on our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |